Merita Xhetani1, Irena Seferi2, Claude Férec3, Grigor Zoraqi4, Yann Fichou5. 1. National Blood Transfusion Centre, Tirana, France Faculty of Natural Sciences, Department of Biology, Tirana, Albania, France. 2. National Blood Transfusion Centre, Tirana, France. 3. French Blood Institute (EFS-Bretagne), Brest, France National Institute of Health and Medical Research (Inserm U1078), Brest, France Faculty of Medicine and Health Sciences, University of West Bretagne, Brest, France Molecular Genetics and Histocompatibility Laboratory, Regional University Hospital (CHRU), Morvan Hospital, Brest, France. 4. Faculty of Natural Sciences, Department of Biology, Tirana, Albania, France. 5. French Blood Institute (EFS-Bretagne), Brest, France National Institute of Health and Medical Research (Inserm U1078), Brest, France.
Abstract
BACKGROUND: Determination of Rhesus (Rh) status is of critical importance in the field of both transfusion and obstetric medicine. As the distribution of Rh phenotypes was unknown in the Albanian population, we investigated the donor population in Albania to estimate the prevalence of each phenotype, as well as to identify and characterise the variants at the molecular level. MATERIALS AND METHODS: A total of 38,836 blood donors were phenotyped for Rh D, C, c, E and e antigens by routine serological methods, and samples with reduced D antigen expression underwent molecular characterisation by a Tm-shift genotyping method and direct sequencing. RESULTS: Among all donors 89.00% and 10.86% were D-positive and D-negative, respectively, while 0.14% (n=55) of the donors were found to be weak D-positive. Overall 45/55 samples (81.8%) were resolved by Tm-shift screening, showing that approximately 67% of the variant D alleles were weak D type 1, while weak D type 3 (9.1%) and weak D type 2 (3.6%) were less common. A novel c.932A>G (p.Y311C) variant was also found in the heterozygous state by direct sequencing. DISCUSSION: This extensive study reveals the distribution of Rh phenotypes in the Albanian population, the low prevalence of individuals with a weak D phenotype, and the specific pattern of distribution of the three most common variant alleles in this Caucasian population.
BACKGROUND: Determination of Rhesus (Rh) status is of critical importance in the field of both transfusion and obstetric medicine. As the distribution of Rh phenotypes was unknown in the Albanian population, we investigated the donor population in Albania to estimate the prevalence of each phenotype, as well as to identify and characterise the variants at the molecular level. MATERIALS AND METHODS: A total of 38,836 blood donors were phenotyped for Rh D, C, c, E and e antigens by routine serological methods, and samples with reduced D antigen expression underwent molecular characterisation by a Tm-shift genotyping method and direct sequencing. RESULTS: Among all donors 89.00% and 10.86% were D-positive and D-negative, respectively, while 0.14% (n=55) of the donors were found to be weak D-positive. Overall 45/55 samples (81.8%) were resolved by Tm-shift screening, showing that approximately 67% of the variant D alleles were weak D type 1, while weak D type 3 (9.1%) and weak D type 2 (3.6%) were less common. A novel c.932A>G (p.Y311C) variant was also found in the heterozygous state by direct sequencing. DISCUSSION: This extensive study reveals the distribution of Rh phenotypes in the Albanian population, the low prevalence of individuals with a weak D phenotype, and the specific pattern of distribution of the three most common variant alleles in this Caucasian population.
Authors: M Belledi; E S Poloni; R Casalotti; F Conterio; I Mikerezi; J Tagliavini; L Excoffier Journal: Eur J Hum Genet Date: 2000-07 Impact factor: 4.246
Authors: T H Müller; F F Wagner; A Trockenbacher; N I Eicher; W A Flegel; D Schönitzer; F Schunter; C Gassner Journal: Transfusion Date: 2001-01 Impact factor: 3.157
Authors: F Araújo; M-J Rodrigues; F Monteiro; T Chabert; G Tavares; G Sousa; J Storry; J-E Guimarães Journal: Transfus Med Date: 2006-02 Impact factor: 2.019
Authors: B H Faas; E A Beckers; P Wildoer; P C Ligthart; M A Overbeeke; H A Zondervan; A E von dem Borne; C E van der Schoot Journal: Transfusion Date: 1997-01 Impact factor: 3.157
Authors: B K Singleton; C A Green; N D Avent; P G Martin; E Smart; A Daka; E G Narter-Olaga; L M Hawthorne; G Daniels Journal: Blood Date: 2000-01-01 Impact factor: 22.113